Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Akebia Therapeutics (AKBA)

Akebia Therapeutics (AKBA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Akebia Therapeutics 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 USA

P: 617-871-2098 F: 617-871-2099

Description:

Akebia Therapeutics Inc. is a biopharmaceutical company. It focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor biology for patients with kidney disease. Akebia Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 393,440
Shares Outstanding, K 118,864
Annual Sales, $ 207,740 K
Annual Net Income, $ -143,590 K
Last Quarter Sales, $ 100,800 K
Last Quarter Net Income, $ -58,170 K
60-Month Beta 1.51
% of Insider Shareholders 2.66%
% of Institutional Shareholders 71.91%
Float, K 115,702
% Float 97.34%

Growth:

1-Year Return -57.01%
3-Year Return -62.83%
5-Year Return -76.73%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -86.26%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/12/19
Earnings Per Share ttm -2.11
EPS Growth vs. Prev Qtr 6.67%
EPS Growth vs. Prev Year 39.13%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

AKBA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -3.38
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -31.23
Return-on-Assets (Before Tax) -19.83
Profit Margin % -69.12
Net Margin % N/A
Debt/Equity 0.06
Price/Sales 1.91
Price/Cash Flow N/A
Price/Book 0.84
Book Value/Share 4.41
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar